Skip to main content

Diagnostic options · UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 781–795 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-2909
PIIINP (Procollagen Type III Amino Terminal Propeptide) Test

This diagnostic test evaluates the level of procollagen type III amino-terminal propeptide in serum to assess active fibrogenesis.

Serum Next-day reporting (samples received Mon–Thu by 4:00 PM) 850.00 AED
View
View test specifications and preparation
What it measures
["Procollagen Type III Amino-Terminal Propeptide", "Fibrogenesis activity"]
Parameters
[{"name": "Procollagen Type III Amino-Terminal Propeptide", "reference_range": null}]
Preparation
["Overnight fasting is preferred.", "Maintain normal hydration unless advised otherwise.", "Avoid strenuous exercise 24 hours prior.", "Inform phlebotomist of any anticoagulant therapy."]
Indications
["Assessment of hepatic fibrosis", "Monitoring of chronic liver disease", "Evaluation of systemic sclerosis", "Assessment of skin fibrosis"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 34533-5 ICD-10: K74.60
Clinical summary
This diagnostic test evaluates the level of procollagen type III amino-terminal propeptide in serum to assess active fibrogenesis.
TEST-1231
PIK3CA Gene Analysis by Next‑Generation Sequencing (NGS) Test

This test evaluates the PIK3CA gene for somatic mutations using Next-Generation Sequencing (NGS). It identifies variants associated with solid tumours and overgrowth syndromes.

Peripheral Whole Blood (10 mL) 10–15 Working Days 4,000.00 AED
View
View test specifications and preparation
What it measures
["Somatic mutations in the PIK3CA gene", "Variant allele frequency (down to 1%)"]
Parameters
[]
Preparation
[]
Indications
["Diagnosis and treatment guidance for solid tumours", "Risk assessment for overgrowth syndromes"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21626-4 ICD-10: Z15.09
Clinical summary
This test evaluates the PIK3CA gene for somatic mutations using Next-Generation Sequencing (NGS). It identifies variants associated with solid tumours and overgrowth syndromes.
TEST-3864
PIK3R5 Gene Ataxia‑Oculomotor Apraxia Type 3 Genetic Test

This test identifies pathogenic variants in the PIK3R5 gene, confirming a diagnosis of Ataxia-Oculomotor Apraxia Type 3 (AOA3).

Peripheral Blood (EDTA), Extracted DNA, or FTA Card 3–4 Weeks (21–28 Business Days) 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PIK3R5 gene"]
Parameters
[]
Preparation
["Mandatory pre-test genetic counselling session", "Three-generation pedigree chart required"]
Indications
["Suspected Ataxia-Oculomotor Apraxia Type 3 (AOA3)", "Family history of AOA3"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: G11.1
Clinical summary
This test identifies pathogenic variants in the PIK3R5 gene, confirming a diagnosis of Ataxia-Oculomotor Apraxia Type 3 (AOA3).
TEST-3089
PITX2 Gene Axenfeld‑Rieger Syndrome Type 1 Genetic Test

This genetic test analyzes the PITX2 gene to identify mutations associated with Axenfeld‑Rieger syndrome type 1.

Peripheral whole blood (3–5 mL in EDTA) 21–28 calendar days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PITX2 gene", "Copy-number variants (deletions/duplications) in the PITX2 gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any recent blood transfusions"]
Indications
["Suspicion of Axenfeld‑Rieger syndrome type 1", "Family history of Axenfeld‑Rieger syndrome", "Cascade screening for at-risk family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55131-5 ICD-10: Q13.8
Clinical summary
This genetic test analyzes the PITX2 gene to identify mutations associated with Axenfeld‑Rieger syndrome type 1.
TEST-3081
PITX3 Gene Anterior Segment Mesenchymal Dysgenesis Genetic Test

This test evaluates the PITX3 gene for pathogenic variants associated with anterior segment eye development disorders.

Peripheral whole blood (2-3 mL in EDTA) 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PITX3 gene sequence", "Pathogenic variants", "Copy Number Variations (CNV)"]
Parameters
[]
Preparation
["No fasting required", "No special diet required", "No medication withholding required"]
Indications
["Diagnosis of suspected PITX3-related disorders", "Family planning risk assessment", "Guiding surgical timing"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21617-1 ICD-10: Q15.0, Q12.0, Q13.81
Clinical summary
This test evaluates the PITX3 gene for pathogenic variants associated with anterior segment eye development disorders.
TEST-5670
PJVK Gene (DFNB59) Sequencing Test

This test evaluates the PJVK gene for pathogenic variants associated with autosomal recessive non-syndromic sensorineural hearing loss (DFNB59).

Peripheral Whole Blood (3–5 mL EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PJVK gene", "Single-nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variations (CNVs)", "Large structural rearrangements"]
Parameters
[]
Preparation
["No specific fasting required", "Inform the phlebotomist of any medications being taken"]
Indications
["Diagnosis of autosomal recessive non-syndromic sensorineural hearing loss (DFNB59)", "Family planning for individuals with a family history of DFNB59", "Carrier screening in families with a history of DFNB59"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48766-5 ICD-10: Z15.89, H90.3, Z13.71
Clinical summary
This test evaluates the PJVK gene for pathogenic variants associated with autosomal recessive non-syndromic sensorineural hearing loss (DFNB59).
TEST-3541
PKHD1 Gene (Polycystic Kidney Disease Type 1, Autosomal Recessive) Genetic Test

This test identifies pathogenic variants in the PKHD1 gene, confirming a diagnosis of Autosomal Recessive Polycystic Kidney Disease (ARPKD).

Peripheral whole blood (3–5 mL EDTA) or FTA card DNA specimen 3–4 Weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PKHD1 gene", "Exon and splice-site coverage of the PKHD1 gene"]
Parameters
[]
Preparation
["No fasting required", "Inform phlebotomist if on anticoagulant therapy", "Pre-test genetic counselling session required 24 hours prior to collection"]
Indications
["Infants with enlarged echogenic kidneys", "Children presenting with portal hypertension or congenital hepatic fibrosis", "Adults with unexplained hepatorenal fibrocystic disease", "Individuals with a positive family history of ARPKD"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 92547-4 ICD-10: Q61.1
Clinical summary
This test identifies pathogenic variants in the PKHD1 gene, confirming a diagnosis of Autosomal Recessive Polycystic Kidney Disease (ARPKD).
TEST-3934
PKHD1L1 Gene Autism, PKHD1L1-related Genetic Test

This test identifies genetic variants in the PKHD1L1 gene associated with autism spectrum disorders.

Whole blood (5 ml EDTA tube), FTA card dried blood spot, or extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PKHD1L1 gene", "Single-nucleotide variants", "Insertions", "Deletions", "Splice-site mutations"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any known haematological disorders"]
Indications
["Diagnosis of autism spectrum disorder", "Familial risk stratification", "Genetic counselling", "Cases where chromosomal microarray is negative"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94230-0 ICD-10: F84.0
Clinical summary
This test identifies genetic variants in the PKHD1L1 gene associated with autism spectrum disorders.
TEST-3359
PKLR Gene Adenosine Triphosphate, Elevated Erythrocytes Genetic Test

This genetic test analyzes the PKLR gene to identify mutations associated with pyruvate kinase deficiency, a cause of chronic hemolytic anemia.

Peripheral Whole Blood (EDTA tube) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PKLR gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"]
Parameters
[]
Preparation
["No fasting or special preparation required", "Mandatory pre-test genetic counselling session"]
Indications
["Definitive molecular diagnosis of pyruvate kinase deficiency", "Carrier screening", "Informed genetic counselling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 60230-6 ICD-10: D55.0
Clinical summary
This genetic test analyzes the PKLR gene to identify mutations associated with pyruvate kinase deficiency, a cause of chronic hemolytic anemia.
TEST-5837
PKLR Gene Pyruvate Kinase Deficiency with Hemolytic Anemia Genetic Test

This test identifies pathogenic variants in the PKLR gene associated with pyruvate kinase deficiency, a cause of hereditary non-spherocytic hemolytic anemia.

Peripheral Whole Blood (3–5 mL in EDTA), Extracted DNA, or FTA Card Dried Blood Spot 21–28 Calendar Days 2,800.00 AED
View
View test specifications and preparation
What it measures
["PKLR gene pathogenic variants", "Single nucleotide variants", "Small insertions and deletions", "Copy number changes"]
Parameters
[]
Preparation
["No fasting required", "Inform collection team if on anticoagulant therapy"]
Indications
["Diagnosis of hereditary non-spherocytic hemolytic anemia", "Carrier screening", "Family planning", "Risk stratification"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: D55.0
Clinical summary
This test identifies pathogenic variants in the PKLR gene associated with pyruvate kinase deficiency, a cause of hereditary non-spherocytic hemolytic anemia.
TEST-4431
PKP2 Gene (Arrhythmogenic Right Ventricular Cardiomyopathy Type 9) Genetic Test

This genetic test identifies pathogenic variants in the PKP2 gene associated with Arrhythmogenic Right Ventricular Cardiomyopathy Type 9 (ARVC9).

Whole blood (peripheral) 3–4 weeks (expedited available) 2,800.00 AED
View
View test specifications and preparation
What it measures
["PKP2 gene sequence", "Copy Number Variations (CNVs) in PKP2"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any current anticoagulation therapy"]
Indications
["Diagnosis of suspected ARVC9", "Family cascade screening for ARVC9", "Pre-sports clearance evaluation", "Risk stratification in individuals with unexplained cardiac symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 38177-0 ICD-10: I42.8
Clinical summary
This genetic test identifies pathogenic variants in the PKP2 gene associated with Arrhythmogenic Right Ventricular Cardiomyopathy Type 9 (ARVC9).
TEST-3653
PLA2G5 Gene Familial Benign Fleck Retina Genetic Test

This test evaluates the PLA2G5 gene for pathogenic variants associated with familial benign fleck retina.

Whole Blood (EDTA), Extracted DNA, or FTA Card Blood Spot 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PLA2G5 gene", "Genetic predisposition to familial benign fleck retina"]
Parameters
[]
Preparation
["No fasting required", "No medication adjustments required"]
Indications
["Suspected familial benign fleck retina", "Family history of inherited retinal dystrophy", "Genetic counseling for at-risk relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82326-5 ICD-10: H35.59
Clinical summary
This test evaluates the PLA2G5 gene for pathogenic variants associated with familial benign fleck retina.
TEST-2522
Plasma Free Metanephrines Test

This test measures free metanephrines and normetanephrines in plasma to screen for pheochromocytoma and paraganglioma.

Plasma (Peripheral Blood) 2–4 business days 1,200.00 AED
View
View test specifications and preparation
What it measures
["Free Metanephrine", "Free Normetanephrine"]
Parameters
[{"name": "Free Metanephrine", "reference_range": null}, {"name": "Free Normetanephrine", "reference_range": null}]
Preparation
["Avoid bananas, nuts, caffeine, chocolate, and caffeinated beverages for 72 hours prior.", "Overnight fasting (8–12 hours) required.", "Rest supine for at least 30 minutes before sample collection.", "Do not take Labetalol, Sotalol, Acetaminophen, Methyldopa, tricyclic antidepressants, ephedrine, amphetamine, or nicotine during the preparation window.", "Inform phlebotomist of all medications and supplements."]
Indications
["Suspected pheochromocytoma", "Suspected paraganglioma", "Evaluation of resistant hypertension", "Evaluation of adrenal incidentalomas"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93938-8 ICD-10: E27.5, D35.0
Clinical summary
This test measures free metanephrines and normetanephrines in plasma to screen for pheochromocytoma and paraganglioma.
TEST-2907
Plasma Renin Direct Test

This diagnostic test evaluates the renin-angiotensin system by directly measuring plasma renin concentration.

Plasma Same Day (Collection Tuesday/Friday by 11 AM; Report issued same day) 1,000.00 AED
View
View test specifications and preparation
What it measures
["Plasma Renin Concentration", "Renin-Angiotensin System Activity"]
Parameters
[{"name": "Plasma Renin Direct", "reference_range": null}]
Preparation
["Maintain upright posture for 2 hours prior to collection", "Follow specific medication washout instructions provided by your clinician"]
Indications
["Diagnosis of primary aldosteronism", "Evaluation of renal artery stenosis", "Investigation of resistant hypertension", "Monitoring response to antihypertensive therapy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 2144-1 ICD-10: I10
Clinical summary
This diagnostic test evaluates the renin-angiotensin system by directly measuring plasma renin concentration.
TEST-5120
PLEC Gene Epidermolysis Bullosa Simplex (Ogna Type) NGS Genetic Analysis Test

This test identifies pathogenic variants in the PLEC gene associated with Ogna-type epidermolysis bullosa simplex.

Blood, Extracted DNA, FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PLEC gene", "Deletions/Duplications in the PLEC gene"]
Parameters
[]
Preparation
["Pre-test genetic counselling session required", "Informed consent documentation needed"]
Indications
["Suspected Ogna-type epidermolysis bullosa simplex", "Family history of PLEC-related epidermolysis bullosa", "Need for genetic counselling and reproductive planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83039-0 ICD-10: Q81.0, Q81.8, Z14.8
Clinical summary
This test identifies pathogenic variants in the PLEC gene associated with Ogna-type epidermolysis bullosa simplex.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area